MARIANNE RAYNES: Open Payments
NPI 1760900864 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,288 in 106 payments from 10 companies in 2025. Trend: 2023 $3,642 · 2024 $2,739 · 2025 $3,288
Food & beverage: $3,288
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $751 |
| E.R. Squibb & Sons, L.L.C. | 23 | $668 |
| Axsome Therapeutics, Inc. | 8 | $468 |
| Janssen Pharmaceuticals, Inc | 13 | $363 |
| Alkermes, Inc. | 12 | $301 |
| Otsuka America Pharmaceutical, Inc. | 8 | $232 |
| Teva Pharmaceuticals USA, Inc. | 11 | $185 |
| ABBVIE INC. | 3 | $149 |
| Vanda Pharmaceuticals Inc. | 4 | $94 |
| Neurocrine BioSciences, Inc. | 2 | $77 |
Products named: CAPLYTA, COBENFY, Auvelity, INVEGA SUSTENNA, ARISTADA, VRAYLAR, REXULTI, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
